MitraClip® therapy in patients with end-stage systolic heart failure

European Journal of Heart Failure

Volumn 13, Issue 5, 2011, Pages 569-576

  Franzen, Olaf ^a   Van Der Heyden, Jan ^b   Baldus, Stephan ^a   Schlüter, Michael ^a   Schillinger, Wolfgang ^c   Butter, Christian ^d   Hoffmann, Rainer ^e   Corti, Roberto ^f   Pedrazzini, Giovanni ^g   Swaans, Martin J ^b   Neuss, Michael ^d   Rudolph, Volker ^a   Sürder, Daniel ^g   Grünenfelder, Jürg ^f   Eulenburg, Christine ^h   Reichenspurner, Hermann ^a   Meinertz, Thomas ^a   Auricchio, Angelo ^g  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Heart Center Brandenburg   (Germany)

^e RWTH AACHEN UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g DIVISION OF CARDIOLOGY   (Switzerland)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Catheter based therapy; Heart failure; Heart valves; Mitral regurgitation

Indexed keywords

AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLIP; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC CARDIOMYOPATHY; MALE; MINIMALLY INVASIVE PROCEDURE; MITRACLIP; MITRAL VALVE REGURGITATION; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME; WALKING;

AGED; COMORBIDITY; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSTHESES AND IMPLANTS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79955404843     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr029     Document Type: Article

References (19)

1. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003;91:360-362. (Pubitemid 36143884)
2. Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-543. (Pubitemid 36263251)
3. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41: 765-770. (Pubitemid 36308383)
4. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28:1083-1091. (Pubitemid 26376978)
5. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update incorporated into the ACC/ AHA 2005 guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-e479. Erratum in: Circulation 2010;121:e258.
6. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D, EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-694.
7. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, Treede H, Barmeyer A, Schofer J, Costard-Jäckle A, Schlüter M, Reichenspurner H, Meinertz T. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-1381.
8. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S, Colombo A, Giacomini A, Michev I, Mangiafico S, Cammalleri V, Barbanti M, Alfieri O. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010;31:1382-1389.
9. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802. (Pubitemid 37391035)
10. Foster E, Wasserman HS, Gray W, Homma S, Di Tullio MR, Rodriguez L, Stewart WJ, Whitlow P, Block P, Martin R, Merlino J, Herrmann HC, Wiegers SE, Silvestry FE, Hamilton A, Zunamon A, Kraybill K, Gerber IL, Weeks SG, Zhang Y, Feldman T. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100:1577-1583. (Pubitemid 350050867)
11. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-387. (Pubitemid 40186788)
12. McGee EC, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F, Shiota T, Sabik JF, Lytle BW, McCarthy PM, Cosgrove DM. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004;128:916-924. (Pubitemid 39575298)
13. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, Blackstone EH, Lytle BW. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191-2201. (Pubitemid 46817809)
14. Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL, Jessup M, Sabbah HN, Starling RC, Kubo SH, Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006;132:568-577.
15. Kotlyar E, Hayward CS, Keogh AM, Feneley M, Macdonald PS. The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter. Heart 2004;90:800-801. (Pubitemid 38813644)
16. Khattar RS. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure. Minerva Cardioangiol 2003;51:143-154. (Pubitemid 36827932)
17. Liang YJ, Zhang Q, Fung JW, Chan JY, Yip GW, Lam YY, Yu CM. Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy. Eur Heart J 2010;31: 2359-2368.
18. Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, Boersma E, Dion RA. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg 2005;27:847-853. (Pubitemid 40585680)
19. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-1443.